Gilead Sciences, Inc. - Jun 17, 2024 Form 4 Insider Report for ASSEMBLY BIOSCIENCES, INC. (ASMB)

Role: 10%+ Owner
Signature: Gilead Sciences, Inc. By: /s/ Andrew D. Dickinson
Stock symbol: ASMB
Transactions as of: Jun 17, 2024
Transactions value $: $0
Form type: 4
Date filed: 6/20/2024, 08:31 PM
Previous filing: Apr 19, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ASMB	Common Stock	Purchase		+180K	+16.48%		1.27M	Jun 17, 2024	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ASMB	Warrant to purchase Common Stock	Purchase		+180K			180K	Jun 17, 2024	Common Stock	180K	$17.00	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Pursuant to a securities purchase agreement between the Issuer and the Reporting Person, the Issuer issued and sold to the Reporting Person in a private placement 179,500 shares of the Issuer's common stock, par value $0.001 per share ("Common Stock"), and a warrant to purchase 179,500 shares of Common Stock (the "Warrant") at a combined price of $15.46 per share of Common Stock and accompanying warrant.
F2	The Warrant is exercisable at any time after the date of issuance and expires on June 18, 2029. A holder of the Warrant may not exercise the Warrant if the holder, together with its affiliates, would beneficially own more than 19.99% of the number of shares of Common Stock outstanding immediately after giving effect to such exercise.

Content

Pursuant to a securities purchase agreement between the Issuer and the Reporting Person, the Issuer issued and sold to the Reporting Person in a private placement 179,500 shares of the Issuer's common stock, par value $0.001 per share ("Common Stock"), and a warrant to purchase 179,500 shares of Common Stock (the "Warrant") at a combined price of $15.46 per share of Common Stock and accompanying warrant.

The Warrant is exercisable at any time after the date of issuance and expires on June 18, 2029. A holder of the Warrant may not exercise the Warrant if the holder, together with its affiliates, would beneficially own more than 19.99% of the number of shares of Common Stock outstanding immediately after giving effect to such exercise.